Shanghai Kaibao (300039)
SZSE · 300039
Market Cap$5.3B
Revenue$1.0B
Employees1197
Listed OnSZSE
Ticker300039
CEO / ExecMr. Yingbin Zhou
HeadquartersShanghai
MarketMainland China
Websitewww.xykb.com
Overview
Shanghai Kaibao Pharmaceutical CO.,Ltd engages in the research, development, production, and sale of modern traditional Chinese medicines primarily in China. The company offers heat-clearing and detoxifying products, such as Tanreqing Injection for wind-heat in the lungs with phlegm-heat obstructing the lungs, early-stage pneumonia, acute bronchitis, acute exacerbations of chronic bronchitis, and respiratory infections; and Phlegm-Heat Clearing Capsules to clear heat, resolve phlegm, and detoxif
Data Note
This record combines exchange-directory fields with selected profile enrichment. Treat market data, leadership and financial figures as directional unless verified against company filings, exchange announcements or the issuer's own disclosures.